GelStat Corporation (“GelStat” or the “Company”) (OTC:GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security and clean energy industries, today announced that its recently formed subsidiary, GSAC Engineering (“GSACe”), has concluded the purchase of certain key intellectual property assets from Duos Technologies Group, Inc. (NASDAQ:DUOT) (“Duos”).
AIM ImmunoTech Completes Treatment Of Last Subject In Phase 2 Study Evaluating Ampligen For The Treatment Of Post-COVID Conditions
No severe adverse events reported to dateTopline data expected as early as Q1 2024OCALA, Fla., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced the last
